Speaker: Markus Zeitlinger, Head of Department, Department of Clinical Pharmacology, Medical University of Vienna (Austria)
Moderator: Markus Heep, Medical Lead Zoliflodacin programme, GARDP (Switzerland)
In this webinar, Markus Zeitlinger gave an overview of different goals of phase 1 studies of antibiotic drug development.
Topics discussed included:
- Combination of several aims in one study
- What do I need to extrapolate antimicrobial efficacy based on phase 1
- Most frequent questions during scientific advice
This live webinar including interactive Q&A session was broadcast on 30 June 2020.
If you have questions or comments, please let us know: email@example.com.